Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds of an animal or human body; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers used to measure human body temperature; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication in the form of a mist; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pads used for therapy; and anti-decubitus mattresses. In addition, the company operates Rossmax healthstyle app, which allows customers to monitor blood pressure, blood glucose, SpO2, weight, and temperature through a single app. It provides healthcare products in the fields of cardiovascular, diabetes, respiratory, fever, and wound healing diseases, as well as thermometers, scales, and nebulizers for kidshealth. The company also exports its products. It operates in Taiwan, Italy, Brazil. Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, Turkey, and internationally. Rossmax International Ltd. was founded in 1988 and is based in Taipei, Taiwan.
Metrics to compare | 4121 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4121PeersSector | |
---|---|---|---|---|
P/E Ratio | −31.0x | −199.1x | −0.5x | |
PEG Ratio | 0.23 | −2.32 | 0.00 | |
Price/Book | 0.9x | 6.1x | 2.6x | |
Price / LTM Sales | 0.3x | 9.7x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 40.3% | |
Fair Value Upside | Unlock | −10.1% | 4.7% | Unlock |